Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Matthews

Showing results (1041-1050 of 1,238) with videos related to

Pageof 124
Sort By:
The Journal of Experimental Medicine|March 1, 1993
Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope proteinB F Haynes, L O Arthur, P Frost, et al.
Annals of Internal Medicine|August 15, 1996
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation GroupB S Graham, M C Keefer, M J McElrath, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibodyW G Robey, L O Arthur, T J Matthews, et al.
Science Advances|September 4, 2024
High absorptivity nanotextured powders for additive manufacturingOttman A Tertuliano, Philip J DePond, Andrew C Lee, et al.
Annals of Internal Medicine|September 1, 1985
Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-upB E Johnson, D C Ihde, P A Bunn, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1987
A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitopeT J Palker, T J Matthews, M E Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignanciesI N Micallef, D M Lillington, J Apostolidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphomaD M Lillington, I N Micallef, E Carpenter, et al.
The American Journal of Medicine|June 1, 1986
Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancerB E Johnson, D C Ihde, M J Matthews, et al.
NPP - Digital Psychiatry and Neuroscience|December 6, 2024
A translationally informed approach to vital signs for psychiatry: a preliminary proof of conceptMeredith L Wallace, Ellen Frank, Colleen A McClung, et al.
Pageof 124

Showing results (1041-1050 of 1,238) with videos related to

Sort By:
Pageof 124
The Journal of Experimental Medicine|March 1, 1993
Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope proteinB F Haynes, L O Arthur, P Frost, et al.
Annals of Internal Medicine|August 15, 1996
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation GroupB S Graham, M C Keefer, M J McElrath, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibodyW G Robey, L O Arthur, T J Matthews, et al.
Science Advances|September 4, 2024
High absorptivity nanotextured powders for additive manufacturingOttman A Tertuliano, Philip J DePond, Andrew C Lee, et al.
Annals of Internal Medicine|September 1, 1985
Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-upB E Johnson, D C Ihde, P A Bunn, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1987
A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitopeT J Palker, T J Matthews, M E Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignanciesI N Micallef, D M Lillington, J Apostolidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphomaD M Lillington, I N Micallef, E Carpenter, et al.
The American Journal of Medicine|June 1, 1986
Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancerB E Johnson, D C Ihde, M J Matthews, et al.
NPP - Digital Psychiatry and Neuroscience|December 6, 2024
A translationally informed approach to vital signs for psychiatry: a preliminary proof of conceptMeredith L Wallace, Ellen Frank, Colleen A McClung, et al.
Pageof 124